Blood test to help decide if prostate biopsy is needed
Part of Cancer, Kidney & urinary clinical trials.
This study tests whether a new blood test called Proclarix can better predict which men actually have prostate cancer before they undergo a biopsy. If the test works well, it could help avoid unnecessary biopsies in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 75 years old
- Your PSA blood test score is between 2 and 10 ng/mL (a range that suggests possible prostate cancer risk)
- You are already scheduled to have a prostate biopsy within the next 30 days
- You are willing to give blood samples for the new Proclarix test
- You agree to share your biopsy results and any other prostate-related test results with the study team
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new blood test (Proclarix) to see if it can better predict prostate cancer risk in men who are already scheduled for an MRI and prostate biopsy. The goal is to improve how doctors decide who needs a biopsy.
This study is testing a new blood test, ClarityDX Prostate, to see if it can help doctors better decide who needs a biopsy. It is for men who have been referred to a urologist because there is a suspicion of prostate cancer but who have not been diagnosed yet.
This study uses a blood test to detect prostate cancer more accurately than traditional methods. It looks for genetic material from cancer cells to help decide if a prostate biopsy is needed.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This study uses a new blood test to find DNA fragments that may show early signs of prostate cancer. It is for men with higher PSA levels who already need a prostate biopsy.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
Hear when a new Prostate Cancer Detection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.